Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma

Neuro-Oncology(2022)10.1093/neuonc/noac051Source: DataRank Database

RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma is a research paper published in Neuro-Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.01)OA: bronzeTopics (50)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Huihuang Yan ORCID,Shulan Tian ORCID,Paul A. Decker ORCID,Danielle M. Burgenske ORCID,Katrina K. Bakken ORCID

Live enrichment

PubMed:35231103 OpenAlex:https://openalex.org/W4214516371

National Institutes of Health

Grant: R01CA176830

National Institutes of Health

Grant: R01CA 233522

NCI NIH HHS

Grant: P30 CA015083

FWCI

3.01

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

journalhttps://academic.oup.com/neuro-oncology/article-pdf/24/8/1261/45187351/noac051.pdf

publisherhttps://academic.oup.com/neuro-oncology/article-pdf/24/8/1261/45187351/noac051.pdf

publisherhttps://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noac051/43290058/noac051.pdf

journalhttps://doi.org/10.1093/neuonc/noac051

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35231103

Fields of Study

Glioma Diagnosis and TreatmentGenomics and Chromatin DynamicsHistone Deacetylase Inhibitors ResearchAcetylationAnimalsBrain NeoplasmsCell Line, TumorCell SurvivalDrug Resistance, NeoplasmE1A-Associated p300 ProteinGlioblastomaHumansMicePromoter Regions, GeneticRetinoblastoma-Binding Protein 4TemozolomideXenograft Model Antitumor Assays

MeSH Terms

TemozolomideAcetylationAnimalsBrain NeoplasmsCell SurvivalGlioblastomaHumansPromoter Regions, GeneticDrug Resistance, NeoplasmXenograft Model Antitumor AssaysCell Line, TumorE1A-Associated p300 ProteinMiceRetinoblastoma-Binding Protein 4

Keywords

BiologyCancer researchTemozolomideHistoneEnhancerGene silencingHistone H3GeneO-6-methylguanine-DNA methyltransferaseAcetylationTranscription factorMolecular biologyMethylationMethyltransferaseGliomaGeneticsRBB4/p300 complexglioblastomahistone acetylation

Sustainable Development Goals

SDG 0: Good health and well-being